Showing results for #
Our client, a clinical stage biopharmaceutical company, was not at the point financially or from a headcount standpoint where a large legal and/or compliance team was justified. As a result of this, the overworked general counsel, the sole member of the client’s legal/compliance team, triaged much of the company’s legal work to a network of outside law firms...Read More
A 13-billion dollar global, diversified pharmaceutical company whose M&A capabilities were stretched thin due to a string of deals in a concentrated period of time...Read More
A multinational pharmaceutical company going through several mergers and acquisitions was dealing with a high volume of contracts to be reviewed...Read More
Need help? We're here to help you! Please contact us if you need assistance.